Susan Tousi leaves Illumina to head cancer liquid biopsy startup Delfi. ⁦Jonathan Wosen, Ph.D.⁩ talked to her. Read it here. statnews.com/2024/01/04/ill…

Welcome Susan Tousi to DELFI Diagnostics! Excited to collaborate!

It’s our pleasure to welcome Susan Tousi as DELFI’s new Chief Executive Officer.  We look forward to her guidance in commercial strategy for FirstLook Lung Test in conjunction with Dr. Velculescu continuing as a member of our BOD. Read more below. prnewswire.com/news-releases/…

Tech is enabling bio: NVIDIA ceo Jensen Huang on Recursion - we are entering age of computer-aided drug design.

Congrats Andreas Vandris on well deserved promotion to principal - it's great to collaborate with you across digital health, AI, and SaaS.

Congrats Derek Xiao on your promotion - very excited to continue to collaborate on digital health (including Cartwheel), AI and SaaS!

Welcome Rama Sekhar to Menlo! It's great to be working with you!

He's back 🔥 (via NFL Films) #SBLVIII | George Kittle

Register now to learn about transformation in healthcare: viveevent.com ATTN: Healthcare founders! Menlo’s Bio and Healthcare partner Greg Yap will moderate the Health Tech discussion at #ViVE2024 on Feb 27th at 2 pm, where industry leaders will speak about how we can

My partner Tim Tully is all-in on building the modern AI stack. If you're building with LLMs, check out his new course on RAG and vector databases with Andrew Ng, Pinecone, and DeepLearning.AI! Menlo Ventures

Very excited to back UnstructuredIO as the leader in ETL for LLMs - a core part of the new AI stack and getting better data into AI models. Tim Tully Menlo Ventures

Modern AI stack emerging to drive accuracy/performance that applications like healthcare require: eg UnstructuredIO ETL/data ingestion + Pinecone RAG/vector dbs + Anthropic language models. If you are building in AI x healthcare, we want to help!

Welcome Deedy!

Started the morning strong! @Mmurph was on Bloomberg TV with Ed Ludlow and Caroline Hyde talking about the first AI apps to crack the enterprise and a new playbook from our team at Menlo Ventures that examines the strategies these apps used to break out and distill them into 7

Congratulations to Xaira Therapeutics on the successful launch of its innovative biotech which leverages AI to better understand biological systems and develop new therapeutic approaches. We're entering an era of tremendous innovation and progress in the biotech space, and

Look for the Menlo Cybertruck at RSA today in SF moving cybersecurity entrepreneurs! Fun way to visit Feyza Haskaraman Rama Sekhar Venky Ganesan!

We’re excited to share that Menlo’s own Shawn Carolan has been named to the Forbes Midas List, recognizing the top 100 investors with the best returns. In his 23 years at Menlo Ventures, Shawn has shaped a culture that values thorough analysis, deep dives, and relentless drive. He

Congrats to Shawn Carolan - amazing investor, board member, partner and human!

Good article on "AI Revolutionizing Drug Development" in NYT Steve Lohr. Many years to new drugs, but AI already transformative. Menlo Ventures has been investing in AI/DD for years, including Recursion, Genesis Therapeutics, Vilya, and XairaTherapeutics (last 2 from David Baker).

APPLY NOW! Excited to announce our next partnership with Anthropic : Anthology Fund for accelerating breakthrough applications of AI (including bio and healthcare)! “All In” investors from Menlo Ventures and “bat phone” support credits from Anthropic. cnbc.com/2024/07/17/ant…